基于抗体的疗法在神经瘤学中的作用
Rishab Ramapriyan1,2, Jing Sun1, Annabel Curry1
1Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
Antibodies (Basel, Switzerland)
|November 21, 2023
概括
抗体疗法通过调节免疫系统,对脑瘤有很大的希望. 然而,诸如血脑屏障透等挑战限制了它们的有效性,需要进一步研究中枢神经系统输送和组合策略.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于抗体的疗法,包括免疫检查点抑制剂和免疫调节抗体,正在越来越多地被用于神经瘤学.
- 诸如血脑屏障 (BBB) 透和瘤诱导的免疫抑制等挑战阻碍了临床疗效.
研究的目的:
- 审查神经瘤学中抗体疗法的当前前景观.
- 讨论与这些药物的机制,BBB透和临床经验.
- 探索新兴的目标和先进的治疗策略.
主要方法:
- 对最近的临床试验和对神经瘤学中基于抗体的治疗方法的研究进行文献综述.
- 对作用机制,BBB透数据和临床结果的分析.
- 检查新的标,抗体-药物合物,双特异性T细胞参与剂和CAR T细胞疗法.
主要成果:
- 抗体疗法可以调节瘤的免疫微环境,但显示不确定的临床益处.
- BBB透和瘤免疫抑制是显著的限制.
- 新兴的目标 (TIGIT,LAG3),骨髓模块化和先进的战略显示出潜力.
结论:
- 尽管存在局限性,但抗体疗法对神经瘤学具有重大潜力.
- 未来的研究必须专注于优化中枢神经系统 (CNS) 传递,确定新的点,并开发组合疗法来克服瘤微环境.
相关概念视频
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


